20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with... — RxCUI 1010692
RxNorm drug concept · Semantic branded drug
RxCUI 1010692
Semantic branded drug · SBD
● Current RxNorm concept 13 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1010692
Official name20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asXylocaine 2 % / EPINEPHrine 1:200,000 per 20 ML Injection; Xylocaine 2 % / EPINEPHrine 1:200,000 in 20 ML Injection
FDA products mapped13
Package NDCs mapped29
Reported Medicaid activity (SDUD)103,895 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Epinephrine Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Use it at the first signs of a serious allergic reaction — things like throat tightening, trouble breathing, a drop in blood pressure, severe hives, or vomiting after exposure to a...
- When exactly should I use my epinephrine injection?
- Yes, it really matters. Always inject into the outer thigh — you can even go through your clothing in a hurry. Never use the buttock (that raises the risk of a serious infection ca...
- Where exactly do I inject it, and does it matter?
🕸️ Concept Web — How 20 ML epinephrine 0.005 MG/ML / lidocaine hydroc... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection [Xylocaine with Epinephrine]
RxCUI 1010692 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Epinephrine
3992IN -
Lidocaine
6387IN -
Epinephrine / lidocaine
107602MIN -
Lidocaine hydrochloride
142440PIN
-
Epinephrine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Xylocaine with Epinephrine
746946BN
-
Xylocaine with Epinephrine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Epinephrine / lidocaine Injection
1867937SCDF -
Epinephrine / lidocaine hydrochloride Injection
2645926SCDFP -
Epinephrine / lidocaine Injectable Product
1163879SCDG -
Epinephrine / lidocaine hydrochloride Injectable Product
2661925SCDGP -
Epinephrine / lidocaine Injection [Xylocaine with Epinephrine]
1867939SBDF -
Epinephrine / lidocaine hydrochloride Injection [Xylocaine with Epinephrine]
2654971SBDFP -
Xylocaine with Epinephrine Injectable Product
1186623SBDG -
Injection
1649574DF - +1 more in this family
-
Epinephrine / lidocaine Injection
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
1010688SCD -
Epinephrine 0.005 MG/ML
330427SCDC -
Lidocaine hydrochloride 20 MG/ML
1010670SCDC -
Epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML [Xylocaine with Epinephrine]
1010690SBDC
-
20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
20 ML epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML Injection
SCD · 1010688 -
Epinephrine 0.005 MG/ML
SCDC · 330427 -
Lidocaine hydrochloride 20 MG/ML
SCDC · 1010670 -
Epinephrine / lidocaine Injection
SCDF · 1867937 -
Epinephrine / lidocaine hydrochloride Injection
SCDFP · 2645926 -
Epinephrine / lidocaine Injectable Product
SCDG · 1163879 -
Epinephrine / lidocaine hydrochloride Injectable Product
SCDGP · 2661925
Brand-Name Concepts
-
Epinephrine 0.005 MG/ML / lidocaine hydrochloride 20 MG/ML [Xylocaine with Epinephrine]
SBDC · 1010690 -
Epinephrine / lidocaine Injection [Xylocaine with Epinephrine]
SBDF · 1867939 -
Epinephrine / lidocaine hydrochloride Injection [Xylocaine with Epinephrine]
SBDFP · 2654971 -
Xylocaine with Epinephrine Injectable Product
SBDG · 1186623 -
Xylocaine with Epinephrine
BN · 746946
📦 FDA Products & Package NDCs
13 products · 29 package NDCs
29 package NDCs map to RxCUI 1010692 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00404-9972-20 | 1 VIAL in 1 BAG (0404-9972-20) / 20 mL in 1 VIAL | Xylocaine | Henry Schein, Inc. | 2022-01-10 |
| 63323-0481-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-481-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0482-17 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-17) / 10 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0482-27 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-27) / 20 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0482-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-482-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0483-27 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-483-27) / 20 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0483-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-483-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0484-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-484-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0485-27 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-27) / 20 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0485-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-485-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0486-17 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-17) / 10 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0486-27 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-27) / 20 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0486-57 | 25 VIAL, MULTI-DOSE in 1 TRAY (63323-486-57) / 50 mL in 1 V... | Xylocaine | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0487-17 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-487-17) / 10 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0487-31 | 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-487-31) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0487-37 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-487-37) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0488-17 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-488-17) / 10 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0488-31 | 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-488-31) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0488-37 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-488-37) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0489-17 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-17) / 10 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0489-21 | 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-489-21) / 20 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0489-27 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-489-27) / 20 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0491-57 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-491-57) / 50 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0492-27 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-27) / 2 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0492-31 | 5 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-31) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0492-37 | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-492-37) / 30 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0492-57 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-492-57) / 5 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0495-07 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-495-07) / 5 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
| 63323-0495-27 | 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-495-27) / 2 mL in 1... | Xylocaine MPF | Fresenius Kabi USA, LLC | 2010-08-12 |
Observed labelers:
Fresenius Kabi USA, LLC (28) ·
Henry Schein, Inc. (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.